| Effect of the Sensor Site-Insulin Injection Site Distance on the Dynamics of Local Glycemia in the Minipig Model. | |
| | |
MedLine Citation:
|
PMID: 21355724 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Abstract Background: Previous studies have shown that at the near steady state attained by slow insulin infusion, the local glycemia of subcutaneous fluid tracks the venous glucose concentration (i.e., it is not perturbed by the infusion of insulin). Here we test whether the subcutaneous glycemia near the site of injection of a bolus of insulin is perturbed by the injection in the minipig model without diabetes. Methods: A bolus of short-acting diluted insulin was administered in the animal's flank while three to five continuous glucose monitoring systems measured the subcutaneous glucose concentrations at 0.5, 1, 2, and 3 cm ("near sensors") and at 10-15 cm ("far sensors") from the injection site. Results: We found no statistically significant (P < 0.05) evidence that near and far sensors differ in response time, that is, the elapsed time to onset of signal drop or the elapsed time to minimum signal following insulin injection. We found mixed evidence that near and far sensors differ in the percentage drops at the glycemic minimum. The near versus far difference for near sensors at 0.5 and 3 cm from the injection site was statistically significant (P < 0.05): the average percentage drops for these near sensors were 3% and 11%, respectively, below those for far sensors. We did not find evidence of a difference for near sensors at 1 and 2 cm. Conclusions: Because there is some evidence that insulin injection can cause a minor perturbation (about ≤10%) in the local glycemia, caution is warranted when co-locating glucose sensing and insulin injection sites. |
| | |
Authors:
|
Lesley T Rodriguez; Keith A Friedman; Sheryl S Coffman; Adam Heller |
Related Documents
:
|
680314 - Partial lipodystrophy and insulin-resistant diabetes. 18059574 - Type 2 diabetes mellitus, resistance training, and innate immunity: is there a common l... 11318844 - Correction of hyperglycaemia reduces insulin resistance and serum soluble e-selectin le... 8247074 - Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-depen... 455654 - Diabetic ketoalkalosis. 13638834 - Phenethylbiguanide in diabetic patients; clinical and metabolic effects. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-2-28 |
Journal Detail:
|
Title: Diabetes technology & therapeutics Volume: - ISSN: 1557-8593 ISO Abbreviation: - Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-3-1 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100889084 Medline TA: Diabetes Technol Ther Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Chemical Engineering Department, University of Texas at Austin , Austin, Texas. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Uncoupling intensive insulin therapy from weight gain and hypoglycemia in type 1 diabetes.
Next Document: Associations Between Improved Glucose Control and Patient-Reported Outcomes After Initiation of Insu...